FXR, a target for different diseases.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Histology and Histopathology

• Publication date

  2008-01-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14670/HH-23.621PMID 18283647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular pathogenesis of cholestasis.

  2012cited by this paper
• Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.

  2007cited by this paper
• Regulation of hepatic Insig-2 by the farnesoid X receptor.

  2007cited by this paper
• FXR-activatingg ligands inhibit rabbit ASBT expression viaa FXR-SHP-FTF cascade

  2007cited by this paper
• Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

  2006cited by this paper
• Pregnane X Receptor Is a Target of Farnesoid X Receptor*

  2006cited by this paper
• FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.

  2006cited by this paper
• FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine Published, JLR Papers in Press, October 26, 2005.

  2006cited by this paper
• The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice*

  2006cited by this paper
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006cited by this paper
• Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration

  2006cited by this paper
• Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400292-JLR200

  2005cited by this paper
• Role of Farnesoid X Receptor in the Enhancement of Canalicular Bile Acid Output and Excretion of Unconjugated Bile Acids: A Mechanism for Protection against Cholic Acid-Induced Liver Toxicity

  2005cited by this paper
• Regulation of carbohydrate metabolism by the farnesoid X receptor.

  2005cited by this paper
• Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis

  2005cited by this paper
• Regulation of Complement C3 Expression by the Bile Acid Receptor FXR*

  2005cited by this paper
• Transient impairment of the adaptive response to fasting in FXR‐deficient mice

  2005cited by this paper
• Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.

  2004cited by this paper
• Glucose regulates the expression of the farnesoid X receptor in liver.

  2004cited by this paper
• The farnesoid X receptor induces very low density lipoprotein receptor gene expression

  2004cited by this paper
• Prevention of cholesterol gallstone disease by FXR agonists in a mouse model

  2004cited by this paper
• Farnesoid X receptor represses hepatic lipase gene expression Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.M400221-JLR200

  2004cited by this paper
• Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR

  2004cited by this paper
• Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

  2004cited by this paper
• Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation*

  2003cited by this paper
• Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.

  2003cited by this paper
• Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3*

  2003cited by this paper
• FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.

  2003cited by this paper
• Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation*

  2003cited by this paper
• Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor*

  2003cited by this paper
• Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle*

  2003cited by this paper
• The enzymes, regulation, and genetics of bile acid synthesis.

  2003cited by this paper
• Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

  2002cited by this paper
• Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters.

  2002cited by this paper
• Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor*

  2002cited by this paper
• Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study.

  2002cited by this paper
• BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.

  2002cited by this paper
• Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.

  2002cited by this paper
• Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor*

  2001cited by this paper
• Nuclear receptors and lipid physiology: opening the X-files.

  2001cited by this paper
• Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease

  2001cited by this paper
• Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor*

  2001cited by this paper
• A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

  2000cited by this paper
• The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression*

  2000cited by this paper
• Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor*

  2000cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene

  1999cited by this paper
• Identification of a nuclear receptor that is activated by farnesol metabolites.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers.

  1994cited by this paper

• Bile acid signaling, metabolism, and aging

  2026cites this paper
• Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases.

  2026cites this paper
• FXR-targeted drug discovery: Recent advances and therapeutic perspectives.

  2025cites this paper
• Differential Roles of Individual Bile Acid in Physiology and Disease.

  2025cites this paper
• Impact of Nuclear Receptors on the Control of Bile Acid Metabolism and Synthesis: A Comprehensive Review

  2025cites this paper
• Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease

  2023cites this paper
• Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases

  2023cites this paper
• Metformin attenuates high glucose-induced injury in islet microvascular endothelial cells

  2022cites this paper
• Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer Progression

  2022cites this paper
• The role of gut microbiota in liver regeneration

  2022cites this paper
• Farnesoid X receptor: a potential therapeutic target in multiple organs.

  2021influential citation
• Activation of FXR Suppresses Esophageal Squamous Cell Carcinoma Through Antagonizing ERK1/2 Signaling Pathway

  2021cites this paper
• Nuclear receptors: a bridge linking the gut microbiome and the host

  2021cites this paper
• The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis

  2021cites this paper
• Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease

  2020cites this paper
• Regulation of Human CYP2D6

  2018cites this paper
• TGR5 as New Target in Diabetes Care

  2018cites this paper
• Structure-function studies of β-lactamases

  2018cites this paper
• Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice

  2018influential citation
• The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss

  2017cites this paper
• Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1

  2017cites this paper
• Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations

  2017cites this paper
• Mitochondrial Cholesterol and the Paradox in Cell Death.

  2017cites this paper
• TGR5, Not Only a Metabolic Regulator

  2016influential citation
• Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) – an in silico approach

  2016cites this paper
• Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.

  2015cites this paper
• Guggulsterone for Chemoprevention of Cancer.

  2015cites this paper
• Molecular regulation of organic anion transporting polypeptide 1A2 (OATP1A2)by taurocholic acid in Bewo Cells.

  2014cites this paper
• Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

  2014cites this paper
• Activation of farnesoid X receptor induces RECK expression in mouse liver.

  2014cites this paper
• Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor

  2014cites this paper
• Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: role of the chirality on the biological activity.

  2013cites this paper
• Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction

  2013cites this paper
• Bile Acid Receptors and Liver Cancer

  2013cites this paper
• Simultaneous diastereo- and enantioseparation of farnesoid X receptor (FXR) agonists with a quinine carbamate-based chiral stationary phase

  2012cites this paper
• Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms.

  2012cites this paper
• Unbinding Pathways of GW4064 from Human Farnesoid X Receptor As Revealed by Molecular Dynamics Simulations

  2012cites this paper
• Selection of Hepatocyte-Like Cells from Mouse Differentiated Embryonic Stem Cells and Application in Therapeutic Liver Repopulation

  2012cites this paper
• Can Plasma Bile Salt, Triglycerides, and apoA-V Levels Predict Liver Regeneration?

  2012cites this paper
• Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis

  2012cites this paper
• The role of the farnesoid X receptor in metabolic control

  2011cites this paper
• Nuclear bile acid receptor FXR in the hepatic regeneration.

  2011cites this paper
• Molecular mechanism of liver cancer.

  2011cites this paper
• Transactivation versus transrepression in FXR: lessons learned from other Nuclear Receptors

  2011cites this paper
• Oleanolic acid is a selective farnesoid X receptor modulator

  2010cites this paper
• FXR regulates liver repair after CCl4-induced toxic injury.

  2010cites this paper
• Farnesoid X receptor alleviates age‐related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription

  2009cites this paper
• Review Mitochondrial cholesterol in health and disease

  2009cites this paper
• Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.

  2009cites this paper
• Foetal ‘flat’ bile acids reappear during human liver regeneration after surgery

  2009cites this paper
• Mitochondrial cholesterol in health and disease.

  2009cites this paper
• The glycerophosphoinositols: cellular metabolism and biological functions

  2009cites this paper
• Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.

  2009cites this paper
• Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.

  2008cites this paper
• Étude de l'impact des récepteurs non stéroïdiens sur l'activité androgénique dans les cellules cancéreuses de la prostate

  2008cites this paper
• FXR: a metabolic regulator and cell protector

  2008cites this paper
• Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response

  2008cites this paper